Skip to main content
. 2021 May 29;8(8):ofab281. doi: 10.1093/ofid/ofab281

Table 1.

Baseline Characteristics at the Time of Primary Trial Enrollment (N = 502)

Characteristic Overall Intervention Reenrolled Intervention Not Reenrolled SOC Reenrolled SOC Not Reenrolled
(N = 502) (n = 89) (n = 37) (n = 238) (n = 138)
Self-identified gender
 Female 75 (15) 13 (15) 3 (8) 47 (20) 12 (9)
 Male 427 (85) 76 (85) 34 (92) 191 (80) 126 (91)
Age, y
 18–19 1 (<1) 0 (0) 0 (0) 0 (0) 1 (<1)
 20–29 81 (16) 12 (13) 9 (24) 37 (16) 23 (17)
 30–39 328 (65) 60 (67) 25 (68) 159 (67) 84 (61)
 ≥40 92 (18) 17 (19) 3 (8) 42 (18) 30 (22)
Highest education level
 No schooling 4 (<1) 0 (0) 1 (3) 1 (<1) 2 (1)
 At least some primary school 55 (11) 6 (7) 6 (16) 20 (8) 23 (17)
 At least some secondary school 256 (51) 41 (46) 20 (54) 120 (50) 75 (54)
 At least some technical training 122 (24) 27 (30) 6 (16) 67 (28) 22 (16)
 At least some college or university 65 (13) 15 (17) 4 (11) 30 (13) 16 (12)
Relationship status
 Married 171 (34) 35 (39) 10 (27) 75 (32) 51 (37)
 Living with sexual partner, not married 75 (15) 14 (16) 3 (8) 44 (18) 14 (10)
 Separated, divorced, widowed 104 (21) 16 (18) 8 (22) 43 (18) 37 (27)
 Single 152 (30) 24 (27) 16 (43) 76 (32) 36 (26)
Unemployed (within past 3 mo)
 Yes 305 (61) 56 (63) 22 (59) 145 (61) 82 (59)
 No 197 (39) 33 (37) 15 (41) 93 (39) 56 (41)
Employment statusa
 Employed full-time 149 (30) 22 (25) 14 (38) 67 (28) 46 (33)
 Employed part-time 134 (27) 25 (28) 9 (24) 58 (24) 42 (30)
 Unemployed, seeking work 152 (30) 30 (34) 10 (27) 75 (32) 37 (27)
 Unemployed, not seeking work 63 (13) 10 (11) 4 (11) 37 (16) 12 (9)
 Retired 3 (<1) 1 (1) 0 (0) 1 (<1) 1 (<1)
ART status (self-reported)
 Currently on ART 54 (11) 10 (11) 5 (14) 24 (10) 15 (11)
 Previously on ART 46 (9) 8 (9) 1 (3) 27 (11) 10 (7)
 ART naive 402 (80) 71 (80) 31 (84) 187 (79) 113 (82)
On MOUD (self-reported)
 Yes 109 (22) 20 (22) 8 (22) 55 (23) 26 (19)
 No 393 (78) 69 (78) 29 (78) 183 (77) 112 (81)
Time since HIV diagnosis, y, median (IQR) 1.4 (0.07–6.4) 3.0 (0.13–8.5) 0.10 (0.06–5.5) 1.1 (0.06–5.9) 0.60 (0.08–5.9)
HIV-1 RNA, log10 copies/mL, median (IQR) 4.6 (4.0–5.0) 4.6 (3.9–4.9) 4.8 (4.4–5.0) 4.5 (3.9–4.9) 4.7 (4.1–5.1)
CD4 count, cells/μL, median (IQR) 293 (166–463) 321 (211–507) 256 (139–451) 311 (178–477) 269 (143–406)

Data are presented as No. (%) unless otherwise indicated.

Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; IQR, interquartile range; MOUD, medication for opioid use disorder; SOC, standard of care.

aOne participant refused to answer (intervention reenrolled arm)